Medication info
New Zenfor 10/160 mg (Amlodipine Besylate, Valsartan)

New Zenfor 10/160 mg (Amlodipine Besylate, Valsartan)

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Celix Co., Ltd.
Appearance
Light yellow rectangular film-coated tablet
Packaging
28 tablets (14 tablets/Alu-AluX2)
Approval status
Active

MFDS item code 201501207 · Approved 2015.03.06 · Insurance code 646203800

Summary

Main use
Treatment of essential hypertension not controlled with amlodipine or valsartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using the individual components as described below, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.
Child dose
Administration of this medication is not recommended in pediatric patients under 18 years of age, as its safety and efficacy have not been established.

Ingredients

Manufacturer
Celix Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with amlodipine or valsartan monotherapy

  • Essential hypertension
View approved original text

This medication helps patients with essential hypertension for whom blood pressure control is insufficient with monotherapy of amlodipine or valsartan. By combining the two ingredients, it effectively dilates blood vessels, lowers blood pressure, and contributes to reducing the burden on the heart and kidneys. This supports stable blood pressure control and decreases the risk of complications. Therefore, it is used in the treatment of essential hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using the individual components as described below, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.

Child dose

Administration of this medication is not recommended in pediatric patients under 18 years of age, as its safety and efficacy have not been established.

Precautions

This medication should not be used during pregnancy as it can cause serious harm to the fetus and newborn in the second and third trimesters. Those with allergies to the active ingredients or similar medications should not take this medication. Patients with severe kidney or liver disease, women who are pregnant or breastfeeding, and individuals with a history of specific vascular edema should also refrain from using this medication. Patients who are low in sodium or fluids may have a risk of hypotension, so their conditions should be verified before taking the medication and must follow the doctor's directions. Patients with high serum potassium levels need to be cautious when taking this medication along with potassium-containing medications as potassium levels may increase. Individuals with kidney issues, transplant recipients, or those with a history of vascular edema may require special monitoring while taking this medication. Patients post-heart failure or myocardial infarction should carefully monitor their kidney function and blood pressure while taking this medication, and acute myocardial infarction patients should also be cautious. For patients with aortic valve stenosis or obstructive hypertrophic cardiomyopathy, caution is advised when using this medication. Combining this medication with other drugs that have similar effects may increase the risk of hypotension, renal dysfunction, or hyperkalemia; therefore, combination therapy should be avoided. Caution is needed when driving or operating machinery as dizziness or fatigue may occur. In case of overdose, serious hypotension or cardiac arrhythmias may occur and immediate medical assistance should be sought. It is recommended not to use this medication in children as its safety and efficacy have not been established. For the elderly, similar doses to those for general adults are recommended, but monitoring for adverse reactions is essential. Regularly testing blood pressure, kidney function, and electrolyte levels during the use of this medication is important. If planning to become pregnant or upon realization of pregnancy, it is crucial to stop this medication immediately and consult a doctor. Breastfeeding women are advised against taking this medication.

Side effects

nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, pruritus, joint swelling, low back pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, localized edema, facial swelling, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, renal impairment, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disturbance, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal uneasiness, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroirritability, Stevens-Johnson syndrome, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

Light yellow rectangular film-coated tablet

Package unit

28 tablets (14 tablets/Alu-AluX2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.